BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).EBI
The University of Texas M.D. Anderson Cancer Center
Vialinin A is a ubiquitin-specific peptidase inhibitor.EBI
Tokyo University of Agriculture
Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.EBI
Zhengzhou University
Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy.EBI
Mitobridge, Inc. (An Astellas)
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity.EBI
Rapt Therapeutics
CYCLOALKYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT MODULATE IKZF2BDB
Plexium